BALDR

BALDR performs automated comparison and prioritization of biomarker candidates for type 2 diabetes mellitus by integrating protein, gene, disease-related, text-mined, and experimental data from human and mouse IMI2 RHAPSODY studies.

Key Features:

• Comprehensive data integration: Aggregates protein, gene, and disease-related information from major public repositories alongside text-mining outputs and experimental datasets from human and mouse IMI2 RHAPSODY studies.
• Automated pipeline: Automates comparison and prioritization of biomarker candidates across integrated datasets.
• Comparative outputs: Generates comparative analyses presented as figures and tables enabling direct comparison of up to 20 biomarker candidates.
• Evidence integration: Combines computational text-mining evidence with experimental results to support data-driven prioritization.

Scientific Applications:

• Biomarker discovery and prioritization: Assists identification and ranking of promising biomarkers for type 2 diabetes mellitus using integrated multi-source evidence.
• Candidate selection for validation: Supports selection and resource prioritization for downstream experimental verification of biomarker candidates.

Methodology:

Systematic data integration and analysis using computational text-mining techniques and experimental datasets, processed by an automated pipeline to produce comparative analyses.